Literature DB >> 11691969

Bioterrorism. Smallpox vaccinations: how much protection remains?

J Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11691969     DOI： 10.1126/science.294.5544.985

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  14 in total

1.  Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations.

Authors:  Shuji Hatakeyama; Kyoji Moriya; Masayuki Saijo; Yuji Morisawa; Ichiro Kurane; Kazuhiko Koike; Satoshi Kimura; Shigeru Morikawa
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

2.  Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.

Authors:  Lewis H McCurdy; John A Rutigliano; Teresa R Johnson; Man Chen; Barney S Graham
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection.

Authors:  Jennifer Martinez; Xiaopei Huang; Yiping Yang
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

4.  A mouse-based assay for the pre-clinical neurovirulence assessment of vaccinia virus-based smallpox vaccines.

Authors:  Cheryl X Zhang; Christian Sauder; Tahir Malik; Steven A Rubin
Journal:  Biologicals       Date:  2009-11-06       Impact factor: 1.856

5.  Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice.

Authors:  Liyanage P Perera; Thomas A Waldmann; Joseph D Mosca; Nicole Baldwin; Jay A Berzofsky; SangKon Oh
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

6.  Immunity from smallpox vaccine persists for decades: a longitudinal study.

Authors:  Dennis D Taub; William B Ershler; Mark Janowski; Andrew Artz; Michael L Key; Julie McKelvey; Denis Muller; Bernard Moss; Luigi Ferrucci; Patricia L Duffey; Dan L Longo
Journal:  Am J Med       Date:  2008-12       Impact factor: 4.965

7.  The solution structure of the N-terminal domain of E3L shows a tyrosine conformation that may explain its reduced affinity to Z-DNA in vitro.

Authors:  Jan D Kahmann; Diana A Wecking; Vera Putter; Ky Lowenhaupt; Yang-Gyun Kim; Peter Schmieder; Hartmut Oschkinat; Alexander Rich; Markus Schade
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

8.  A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China.

Authors:  Qiang Liu; Weijin Huang; Jianhui Nie; Rong Zhu; Dongying Gao; Aijing Song; Shufang Meng; Xuemei Xu; Youchun Wang
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

9.  Frequency of revaccination against smallpox.

Authors:  Samuel Baron; Jingzhi Pan; Joyce Poast
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

Review 10.  Extracting key information from historical data to quantify the transmission dynamics of smallpox.

Authors:  Hiroshi Nishiura; Stefan O Brockmann; Martin Eichner
Journal:  Theor Biol Med Model       Date:  2008-08-20       Impact factor: 2.432
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.